PS 05-08 A COMPARATIVE STUDY OF ANEROID BLOOD PRESSURE MEASURING DEVICE AND DIGITAL BLOOD PRESSURE MONITOR VERSUS MERCURY SPHYGMOMANOMETER

2016 ◽  
Vol 34 (Supplement 1) ◽  
pp. e143
Author(s):  
Manish Gutch ◽  
Sukriti Kumar ◽  
Himanshu Reddy ◽  
Narendra Singh
F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 1284
Author(s):  
Elrazi A. Ali ◽  
Saeed M. Omar ◽  
Yassin Ibrahim ◽  
Osama Al-Wutayd ◽  
Ishag Adam

Background: Electronic devices for measuring blood pressure (BP) need to go through independent clinical validation as recommended by different authorities, both in general and specific populations. The aim of this study was to assess the validity of the Omron RS6 (HEM-6221-E) wrist oscillometric devices in obese Sudanese patients. Methods: Of 90 obese individuals invited for recruitment, 33 were included in the study, and had their BP at the level of the wrist measured using Omron RS6 and standard mercury sphygmomanometer. Two observations were made and the mean was taken. BP differences between the two methods for the 33 participants were classified into three categories (≤5, ≤10, and ≤15 mmHg), according to the European Society of Hypertension-International Protocol revision 2010 (ESH-IP2) criteria. This was then used to assess the validity of the tested Omron RS6 device. Results: Participants had a mean age of 56.97 years (standard deviation (SD), 8.75; range, 36-79). Average systolic blood pressure (SBP) was 146.21 mmHg (SD, 23.07; range, 107-182), and average diastolic blood pressure (DBP) was 93.82 mmHg (SD, 16.06; range, 67-128). There was a good agreement between the two observations using the OMRON RS6 and the standard sphygmomanometer: −4 to + 3 mmHg for SBP and −4 to +4 mmHg for DBP, with the mean difference of 1.73±1.11 mmHg for SBP and 1.49±1.02 mmHg for DBP. Conclusion: Thus, the Omron RS6 (HEM-6221-E) is a valid and suitable measure of BP according to ESH-IP2.


Author(s):  
Yasmine Winda Kusumaningtyas ◽  
Tri Bowo Indrato ◽  
M. Prastawa Assalim T.P ◽  
Bedjo Utomo

Sphygmomanometer is a human blood pressure measuring device which has several types such as mercury, digital, and aneroid. At this time, mercury Sphygmomanometer is not allowed to be used anymore considering the side effects of mercury which can harm the skin and even respiration. This study helps to reduce the use of mercury type Sphygmomanometer. The researchers make arduino TFT LCD display based Sphyhmomanometer so that the use of mercury can be reduced and make it easier for users to process measurement. The researchers used the oscillmetry method in making the device to calculate the systolic and diastolic pressure. The result of blood pressure measurement has a systolic error rate of 0,08% and a diastolic error rate 0,09%.


Hypertension ◽  
2012 ◽  
Vol 60 (suppl_1) ◽  
Author(s):  
Sarah Yoon ◽  
Tatiana Nwankwo ◽  
Margaret Carroll ◽  
Yechiam Ostchega

Objectives - Precise, reliable blood pressure (BP) measurement, whether in clinical practice or in epidemiological research, is essential for diagnosis and data interpretation. The study objectives were to compare differences in the prevalence and control of hypertension among adults aged 18 years and older using two standard devices: the mercury sphygmomanometer and the Omron Digital Blood Pressure Monitor (HEM_907XL). Methods - 5,185 individuals aged 18 years and older participated in the National Health and Nutrition Examination Survey 2009-2010 BP methodology study. Hypertension was defined as a mean systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg, or currently taking BP medication. Mean BP was the average of up to three readings for each device. Controlled Hypertension among hypertensives was defined as SBP <140 mmHg and DBP < 90 mmHg. Results - Overall the age-adjusted prevalence of hypertension among adults was higher by mercury measurement (27.7%) than by Omron (26.4%, p <0.05). There were significant differences in hypertension prevalence between the two devices among men (mercury: 28.9% vs. Omron: 26.5%, p < 0.05) and Hispanics (mercury: 25.1% vs. Omron: 22.8%, p < 0.05). The overall hypertension control rate among hypertensives was significantly higher using Omron (64.6%) vs. mercury measurement (57.5%, p <0.05). In subgroup analyses, rates of hypertension control among hypertensives were systematically higher using Omron: for those 40-59 years (mercury: 60.0%; Omron: 67.9%); for those 60 years and older (mercury: 59.7%; Omron: 65.4%); for men (mercury: 54.9%; Omron: 63.9%); women (mercury: 61.5%; Omron: 66.1%,); non-Hispanic whites (mercury: 60.9%; Omron: 68.4%); non-Hispanic blacks(mercury: 48.8%; Omron: 54.3%); and Hispanics (mercury: 34.6%; Omron: 44.8%), ( p <0.05 for all groups). Conclusion - Hypertension prevalence measured by mercury was significantly higher than that measured by the Omron device. Lower Omron readings resulted in apparently higher estimates for the rate of controlled hypertension.


2011 ◽  
Vol 29 ◽  
pp. e176
Author(s):  
G. Stergiou ◽  
N. Karpettas ◽  
A. Kollias ◽  
A. Destounis ◽  
D. Tzamouranis

Sign in / Sign up

Export Citation Format

Share Document